Shares of Rhoen Klinikum AG (ETR:RHK) have received an average recommendation of “Hold” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is €24.06 ($28.65).

RHK has been the subject of a number of analyst reports. DZ Bank AG reissued a “sell” rating on shares of Rhoen Klinikum AG in a report on Monday, May 29th. Baader Bank set a €24.00 ($28.57) price target on Rhoen Klinikum AG and gave the stock a “neutral” rating in a report on Thursday, June 8th. Commerzbank Ag set a €25.00 ($29.76) price target on Rhoen Klinikum AG and gave the stock a “neutral” rating in a report on Tuesday, July 25th. Deutsche Bank AG set a €21.00 ($25.00) price target on Rhoen Klinikum AG and gave the stock a “neutral” rating in a report on Wednesday, July 26th. Finally, Berenberg Bank set a €26.00 ($30.95) price target on Rhoen Klinikum AG and gave the stock a “neutral” rating in a report on Tuesday, August 1st.

COPYRIGHT VIOLATION WARNING: This story was first reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.dailypolitical.com/2017/09/25/brokerages-set-rhoen-klinikum-ag-rhk-target-price-at-24-06.html.

Rhoen Klinikum AG (RHK) traded up 0.329% on Friday, reaching €28.051. The company had a trading volume of 100 shares. The company’s 50-day moving average is €27.56 and its 200-day moving average is €26.35. Rhoen Klinikum AG has a 52-week low of €22.91 and a 52-week high of €28.67. The company has a market capitalization of €1.88 billion and a PE ratio of 438.297.

Rhoen Klinikum AG Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhoen Klinikum AG (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.